Abstract
The importance of the endothelium in vessel wall homeostasis has recently become apparent. The vascular endothelium has been discovered to generate two potent vasodilators, prostacyclin (Moncada et al., 1976) and endothelium-derived relaxing factor (EDRF; Furchgott and Zawadzki, 1980) in response to a number of chemical or mechanical stimuli. Prostacyclin is the most potent inhibitor of platelet aggregation yet discovered (for review see Moncada, 1982). EDRF is an inhibitor of both platelet aggregation (Radomski et al., 1987a) and adhesion (Radomski et al., 1987b).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amezcua, J.L., Dusting, G.J., Palmer, R.M.J. and Moncada, S. Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. Br. J. Pharmacol. 95:830–834, 1988.
Blair, I.A., Barrow, S.E., Waddell, K.A., Lewis, P.J. and Dollery, C.T. Prostacyclin is not a circulating hormone in man. Prostaglandins. 23: 579–589, 1982.
Blough, N.V. and Zafiriou, O.C. Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg. Chem. 24:3502–3504, 1985.
Busse, R. Stimulation of soluble guanylate cyclase activity by endothelium-derived relaxant factor: a general principle of its vasodilator and anti-aggregatory properties. Thromb. Res. Suppl. VII, p. 3, 1987.
Chen, W-Z., Palmer, R.M.J. and Moncada, S. The release of nitric oxide from the rabbit aorta. J. Vasc. Med Biol. In press, 1989.
Dale, H.H. Progress in autopharmacology. A survey of present knowledge of the chemical regulation of certain functions by natural constituents of the tissues. Bull Johns Hopk. Hosp. 53:297–347, 1933
Furchgott, R.F. The role of endothelium in the responses of vascular smooth muscle to drugs. Ann. Rev Pharmacol. Toxicol. 24:175–197, 1984.
Furchgott, R.F. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Mechanisms of Vasodilatation, ed. by Vanhoutte, P.M. Raven Press, New York. Vol. IV:401–414, 1988.
Furchgott, R.F. and Zawadzki, J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:373–376, 1980.
Gruetter, C.A., Gruetter, D.Y., Lyon, J.E., Kadowitz, P.J. and Ignarro, L.J. Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methylhemoglobin. J. Pharmacol Exp. Ther. 219:181–186, 1981.
Gryglewski, R.J., Palmer, R.M.J. and Moncada, S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320: 454–456, 1986.
Hibbs, J.B. Jr., Vavrin, Z. and Taintor, R.R. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550–565, 1987a.
Hibbs, J.B. Jr., Taintor, R.R. and Vavrin, Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235:473–476, 1987b.
Hutchinson, P.J.A., Palmer, R.M.J. and Moncada, S. Comparative pharmacology of EDRF and nitric oxide on vascular strips. Eur. J. Pharmacol. 141:445–451, 1987.
Ignarro, L.J. and Kadowitz, P.J. Pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Ann. Rev. Pharmacol. Toxicol. 25:171–191, 1985.
Ignarro, L.J., Byrns, R.E. and Wood K.S. Biochemical and pharmacological properties of Endothelium-Derived Relaxing Factor and its similarity to nitric oxide radical. In: Mechanisms of Vasodilatation. ed. by Vanhoutte P.M. Raven Press, New York. Vol. IV:427–436, 1988.
Kukovetz, W.R., Holzmann, S. and Poch, G. Function of cyclic GMP in acetylcholine-induced contraction of coronary smooth muscle. Naunyn-Schmiedeberg’s Arch. Pharmacol. 319:29–33, 1982.
Macdonald, P.S., Read, M.A. and Dusting, G.J. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Thromb. Res. 49:437–449, 1988.
Martin, W., Villani, G.M., Jothianandan, D. and Furchgott, R.F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232:708–716, 1985a.
Martin, W., Villani, G.M., Jothianandan, D. and Furchgott, R.F. Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous haemoproteins. J. Pharmacol. Exp. Ther. 233:679–685, 1985b.
Martin, W., Furchgott, R.F., Villani, G.M. and Jothianandan, D. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther. 237:539–547, 1986a.
Martin, W., Smith, J.A. and White, D.G. The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide or bovine retractor penis inhibitory factor. Br. J. Pharmacol. 89:562–571, 1986b.
Moncada, S. Biological importance of prostacyclin. Br. J. Pharmacol. 76:3–31, 1982.
Moncada, S., Gryglewski, R., Bunting, S. and Vane, J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 263:663–665, 1976.
Moncada, S., Palmer, R.M.J. and Gryglewski, R.J. Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA. 83:9164–9168, 1986.
Moncada, S., Palmer, R.M.J. and Higgs, E.A. Prostacyclin and endothelium-derived relaxing factor: biological interactions and significance. In: Thrombosis and Haemostasis Verstraete, M., Vermylen, J., Lijnen, H.R., Arnout, J. ed. by Leuven University Press, pp. 587–618, 1987.
Moncada, S., Palmer, R.M.J. and Higgs, E.A. Discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 12:365–372, 1988.
Nakashima, S., Tohmatsu, T., Hattori, H., Okano, Y. and Nozawa, Y. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets. Biochem. Biophys. Res. Commun. 135:1099–1104, 1986.
Palmer, R.M.J., Ferrige, A.G. and Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:524–526, 1987.
Palmer, R.M.J., Ashton, D.S. and Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:664–666, 1988a.
Palmer, R.M.J., Rees, D.D., Ashton, D.S. and Moncada, S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153:1251–1256, 1988b.
Radomski, M.W., Palmer, R.M.J. and Moncada, S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92:181–187, 1987a.
Radomski, M.W., Palmer, R.M.J. and Moncada, S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148:1482–1489, 1987b.
Radomski, M.W., Palmer, R.M.J. and Moncada, S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92:639–646, 1987c.
Radomski, M.W., Palmer, R.M.J. and Moncada, S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. ii: 1057–1058, 1987d.
Radomski, M.W., Palmer, R.M.J., Read, N.G. and Moncada, S. Isolation and washing of human platelets with nitric oxide. Thromb. Res. 50:537–546, 1988.
Rapoport, R.M. and Murad, F. Agonist induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cyclic GMP. Circ. Res. 52:352–357, 1983.
Rees, D.D., Palmer, R.M.J., Hodson, H.F. and Moncada, S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol. In press, 1989.
Rimele, T.J., Sturm, R.J., Adams, L.M., Henry, D.E., Heaslip, R.J., Weichman, B.M. and Grimes, D. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J. Pharm. Exp. Ther. 245:102–111, 1988.
Rubanyi, G.M. and Vanhoutte, P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 250:H222–H227, 1986.
Sneddon, J.M. and Vane, J.R. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc. Natl. Acad. Sci. USA. 85:2800–2804, 1988.
Stuehr, D.J. and Marietta, M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad Sci. USA. 82:7738–7742, 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Moncada, S., Palmer, R.M.J., Higgs, E.A. (1989). Endothelium-Derived Vasodilators. In: Catravas, J.D., Gillis, C.N., Ryan, U.S. (eds) Vascular Endothelium. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8532-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8532-5_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8534-9
Online ISBN: 978-1-4684-8532-5
eBook Packages: Springer Book Archive